| Views | |
|---|---|
| Informed consent and trial prioritization for clinical studies during the COVID-19 pandemic. Stakeholder experiences and viewpoints | 140 |
| October 2025 | November 2025 | December 2025 | January 2026 | February 2026 | March 2026 | April 2026 | |
|---|---|---|---|---|---|---|---|
| Informed consent and trial prioritization for clinical studies during the COVID-19 pandemic. Stakeholder experiences and viewpoints | 29 | 2 | 3 | 12 | 15 | 9 | 15 |
| Views | |
|---|---|
| 2024_Weigold_etal.pdf | 33 |
